A versatile biosensor for detecting Zn and Cu in Alzheimer's disease cells and acidic foods via RNA G-quadruplex hydrolysis.

J Hazard Mater

Beijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry Chinese Academy of Sciences, Beijing 100190, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China. Electronic address:

Published: March 2025

Zinc (Zn) and copper (Cu) are essential micronutrients that also have the potential to act as pollutants, and their imbalance in the human body has been linked to neurodegenerative diseases, particularly Alzheimer's disease (AD). This study presents the development of a versatile RNAzyme-based biosensor capable of selectively detecting Zn and Cu in both Alzheimer's disease model cells and acidic food matrices. This biosensor is composed of a cyanine dye (SCY-5) and an artificially synthesized RNA G-quadruplex (G4). It functions through the specific binding of SCY-5 to G4s, the enzymatic hydrolysis of G4s by RNase T2, and the inhibition of RNase T2 activity by these metal ions. The biosensor effectively tracked variations in Zn and Cu levels within living AD cells, demonstrating a significant correlation between fluctuating metal ion concentrations and the severity of AD pathology. Additionally, it proved efficient in quantifying metal content in acidic foods. These findings highlight the biosensor's dual applicability in monitoring critical metal ion concentrations both in neurodegenerative disease research and in food safety, underscoring its potential as a valuable tool for environmental health and biomedical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhazmat.2025.137847DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
12
detecting alzheimer's
8
cells acidic
8
acidic foods
8
rna g-quadruplex
8
metal ion
8
ion concentrations
8
versatile biosensor
4
biosensor detecting
4
disease
4

Similar Publications

The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances.

J Neurochem

March 2025

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Synaptic homeostasis of the principal neurotransmitters glutamate and GABA is tightly regulated by an intricate metabolic coupling between neurons and astrocytes known as the glutamate/GABA-glutamine cycle. In this cycle, astrocytes take up glutamate and GABA from the synapse and convert these neurotransmitters into glutamine. Astrocytic glutamine is subsequently transferred to neurons, serving as the principal precursor for neuronal glutamate and GABA synthesis.

View Article and Find Full Text PDF

Objectives: epidemiological data show growing numbers of patients with Alzheimer´s disease. Cognitive decline and progressive swallowing impairment lead to a significant deterioration of the nutrition status in this population. Early detection and treatment of malnutrition is important for the prognosis of the disease.

View Article and Find Full Text PDF

Introduction: Alzheimer's disease (AD), a prevalent neurodegenerative disease, is primarily characterized by progressive neuron loss and memory impairment. NOD-like receptors (NLRs) are crucial for immune regulation and maintaining cellular homeostasis. Recently, NLRs have been identified as important contributors to neuroinflammation, thus presenting a potential approach for reducing inflammation and slowing AD progression.

View Article and Find Full Text PDF

Introduction: Ginseng, known as the "king of herbs," has long been used in traditional Chinese medicine due to its beneficial properties, including anti-aging, anti-inflammatory, and anti-apoptotic effects. Ginsenosides, the active compounds in ginseng, have shown promise in treating neurodegenerative diseases such as Alzheimer's disease (AD). This study investigates the therapeutic potential of Ginsenoside Ro and its underlying mechanisms in AD treatment.

View Article and Find Full Text PDF

We examine the relationship between sleep, glymphatics and Alzheimer's disease (AD), and recent work questioning glymphatic clearance during sleep. We highlight a need for understanding glymphatic and/or other mechanism of clearance during sleep, and review glymphatic flow measurement methods. Further, we explore dual orexin receptor antagonists (DORAs) potential to mitigate AD sleep disturbances and enhance clearance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!